Company Filing History:
Years Active: 2010
Title: **Inventor Spotlight: Patrick B. Woodall**
Introduction
Patrick B. Woodall, based in Culpeper, Virginia, is a noted inventor with a deep commitment to the advancement of oral dosage forms. With a patent to his name, he has made significant contributions to the field of pharmaceuticals, particularly in creating compositions that enhance the efficiency and usability of medication.
Latest Patents
Patrick's patent, titled "Quick dissolve compositions and tablets based thereon," focuses on a novel formulation that allows oral dosage forms to dissolve in the mouth within 40 seconds. This innovative composition eliminates the need for conventional super disintegrants while maintaining a friability of less than 1%. The invention employs liquiflash particles combined with an excipient mass, which may include a directly compressible inorganic salt and a cellulose derivative. By optimizing the proportions of these components, the active ingredient is preserved within microspheres, resulting in a dosage form with enhanced hardness and friability.
Career Highlights
Patrick B. Woodall is currently associated with Biovail Laboratories International S.r.l., where he continues to innovate and contribute to pharmaceutical advancements. His background in pharmaceutical sciences allows him to create effective solutions that cater to patient needs through improved drug delivery methods.
Collaborations
Throughout his career, Patrick has collaborated with fellow professionals, including Naima Mezaache and Steven E. Frisbee. These partnerships exemplify the importance of teamwork in driving innovation and enhancing the capabilities of oral dosage forms. Together, they strive to push the boundaries of what's possible in medication delivery, aiming to improve patient outcomes.
Conclusion
In conclusion, Patrick B. Woodall has made noteworthy strides in the pharmaceutical industry with his innovative approaches to oral dosage forms. His patent showcases the potential to transform how patients experience medication. By simplifying the dissolution process, his work holds promise for increased patient compliance and satisfaction, marking him as a significant figure in contemporary pharmaceutical invention.